Vismodegib for giant, locally advanced, basal cell carcinoma and its complex position in clinical practice-Reference-Cited by-同舟云学术

Vismodegib for giant, locally advanced, basal cell carcinoma and its complex position in clinical practice

Published:2019-03 Issue:3 Volume:5 Page:267-270
ISSN:2352-5126
Container-title:JAAD Case Reports
language:en
Short-container-title:JAAD Case Reports

Author:

Koekelkoren Fabiënne H.J.,Roodbergen Sofie L.,Baerveldt Ewout M.,Maat Alexander P.W.M.,Monserez Dominiek A.,Grünhagen Dirk J.,Mureau Marc A.M.,de Haas Ellen R.M.,Nijsten Tamar E.C.,Wakkee Marlies

Funder

STEVIE trial

Roche

Publisher

Elsevier BV

Subject

Dermatology

Reference6 articles.

1. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study;Sekulic;BMC Cancer,2017

2. Efficacy and safety of vismodegib in advanced basal-cell carcinoma;Sekulic;N Engl J Med,2012

3. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib;Chang;J Am Acad Dermatol,2014

4. A comprehensive catalogue of somatic mutations from a human cancer genome;Pleasance;Nature,2010

5. An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma;Ally;J Am Acad Dermatol,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS Study;Dermatology;2023

2. Non-surgical Management of Locally Advanced Basal Cell Carcinoma of the Upper Extremity With Vismodegib;Cureus;2022-08-27

3. A lobulated mass on the upper back with prominent vasculature: A giant basal cell carcinoma;Dermatology Reports;2021-04-07

4. p75NTR/proBDNF Modulates Basal Cell Carcinoma (BCC) Immune Microenvironment via Necroptosis Signaling Pathway;Journal of Immunology Research;2021-02-01

5. Predictive Factors of Non-Response to Vismodegib in Locally Advanced Basal-Cell Carcinoma;Dermatology;2021